logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Physicians'assessments of the utility of health states associated with Human Immunodeficiency Virus (HIV) and Hepatitis B Virus (HBV) Infection.

    Article - En anglais

    An understanding of quality of life (QOL) with human immunodeficiency virus (HIV) is important because the merits of prevention and treatment alternatives may depend substantially on how these interventions affect QOL.

    Physicians'views about QOL are important, because they influence the therapeutic options that physicians consider or offer, the recommendations that physicians make, and because they are important for the analysis of certain policy questions.

    We assessed physicians'utilities of health states associated with HIV infection, and hepatitis B virus (HBV) infection ; assessment of utilities for HBV was included to provide a comparison with HIV utilities.

    We surveyed 200 housestaff and staff physicians in an academic medical centre by anonymous paper-based questionnaire and used the time-tradeoff method to assess physicians'utilities of the health states.

    On a scale in which 0 was equivalent to death, and 1 was equivalent to good health, the median utilities for asymptomatic HIV infection, symptomatic HIV infection, and AIDS were 0.833,0.417, and 0.167, respectively (p<0.01 for each two-way comparison).

    Median utilities for asymptomatic HBV infection, mildly symptomatic HBV infection, and severely symptomatic HBV infection were 0.917,0.667, and 0.167, respectively (p<0.01 for each two-way comparison). (...)

    (résumé d'auteur).

    Mots-clés Pascal : Analyse avantage coût, Maladie, Qualité vie, SIDA, Immunopathologie

    Mots-clés Pascal anglais : Cost benefit analysis, Disease, Quality of life, AIDS, Immunopathology

    Notice produite par :
    ORS Auvergne - Observatoire Régional de la Santé d'Auvergne

    Code Inist : 002B30A11. Création : 16/10/1997.